Hims & Hers Health Inc. (HIMS.US) shares fell more than 7% in pre-market trading on Tuesday, reaching $14.40. The decline followed the company's report of its financial results for the fourth quarter of 2025. Revenue for the quarter was $617.82 million, representing a 28% year-over-year increase but falling short of the expected $619.22 million. Earnings per share came in at $0.08, surpassing the forecast of $0.03. The number of subscribers exceeded 2.5 million; however, the gross margin narrowed to 72% from 77% a year earlier. For the first quarter, the company provided revenue guidance in the range of $600 million to $625 million, which is below the consensus estimate of $653.12 million. For the full 2026 fiscal year, Hims & Hers Health anticipates revenue between $2.7 billion and $2.9 billion, compared to a market expectation of $2.74 billion.